跳至主要内容
临床试验/NCT02219399
NCT02219399已完成不适用

Maternal DHA Supplementation and Pregnancy Outcome

Colorado State University4 个研究点 分布在 1 个国家目标入组 871 人开始时间: 2001年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
871
试验地点
4
主要终点
Cognitive Development

研究概览

简要总结

Supplementation with DHA during pregnancy will increase gestational length and improve cognitive development.

详细描述

This was a trial of supplementation with DHA during pregnancy to increase gestational length. Subjects were provided with 300 mg, 600 mg or placebo (olive oil) in a randomized design from week 24-26 of pregnancy until delivery. Gestational age, birth weight and birth length data were collected and infants growth at 2 and 4 months and cognitive development at 4 months and 1 year were measured.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • singleton pregnancy
  • 18 years of age or older

排除标准

  • cervical incompetence
  • presence of cervical cerclage
  • placenta previa
  • intrauterine infection
  • known substance abuse
  • multiple fetuses
  • current pre-eclampsia
  • preexisting diabetes

结局指标

主要结局

Cognitive Development

时间窗: 12 months

Bayley's Scales of Infant Development measured at 12 months of age

Gestational Length

时间窗: 13 weeks

Length of gestation as measured by Last menstrual period method and US

次要结局

  • Infant Growth Velocity(2 months to 4 months of age)
  • Infant birth weight(13 weeks)
  • Infant head circumference at birth(13 weeks)
  • Infant birth length(13 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

DHA Supplementation and Pregnancy Outcome | 临床试验